These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 16002028

  • 1. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
    Bargagli AM, Schifano P, Davoli M, Faggiano F, Perucci CA, VEdeTTE Study Group.
    Drug Alcohol Depend; 2005 Aug 01; 79(2):191-9. PubMed ID: 16002028
    [Abstract] [Full Text] [Related]

  • 2. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M, Beck O, Leifman A, Romelsjö A, Helander A.
    Drug Alcohol Rev; 2007 Jan 01; 26(1):55-63. PubMed ID: 17364837
    [Abstract] [Full Text] [Related]

  • 3. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.
    Subst Use Misuse; 2006 Jan 01; 41(2):223-44. PubMed ID: 16393744
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes in cocaine use after entry to methadone treatment.
    Magura S, Siddiqi Q, Freeman RC, Lipton DS.
    J Addict Dis; 1991 Jan 01; 10(4):31-45. PubMed ID: 1777498
    [Abstract] [Full Text] [Related]

  • 6. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May 01; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 7. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT, Tait RJ, Hulse GK.
    Arch Gen Psychiatry; 2008 Apr 01; 65(4):457-65. PubMed ID: 18391134
    [Abstract] [Full Text] [Related]

  • 8. [Subjective Quality of Life in opiate-dependent patients before admission after six months and one-year participation in methadone program].
    Habrat B, Chmielewska K, Baran-Furga H, Keszycka B, Taracha E.
    Przegl Lek; 2002 Apr 01; 59(4-5):351-4. PubMed ID: 12184005
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.
    J Psychiatr Pract; 2009 May 01; 15(3):227-34. PubMed ID: 19461397
    [Abstract] [Full Text] [Related]

  • 11. VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population.
    Bargagli AM, Faggiano F, Amato L, Salamina G, Davoli M, Mathis F, Cuomo L, Schifano P, Burroni P, Perucci CA, VEdeTTE Study Group.
    Subst Use Misuse; 2006 May 01; 41(14):1861-79. PubMed ID: 17162594
    [Abstract] [Full Text] [Related]

  • 12. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A.
    Addiction; 2010 Jan 01; 105(1):29-37. PubMed ID: 19922519
    [Abstract] [Full Text] [Related]

  • 13. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Rittmannsberger H, Ruschak M, Silberbauer C.
    Nervenarzt; 1994 May 01; 65(5):338-44. PubMed ID: 8052337
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):188-94. PubMed ID: 16542797
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
    Serpelloni G, Carrieri MP, Rezza G, Morganti S, Gomma M, Binkin N.
    AIDS Care; 1994 Sep 15; 6(2):215-20. PubMed ID: 8061081
    [Abstract] [Full Text] [Related]

  • 20. Drug czar seeks new emphasis on methadone treatment.
    AIDS Policy Law; 1997 Oct 31; 12(20):7. PubMed ID: 11364789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.